176 related articles for article (PubMed ID: 37593245)
1. Design, Synthesis, ADME, and Anticancer Studies of Newer
Agarwal M; Afzal O; Salahuddin ; Altamimi ASA; Alamri MA; Alossaimi MA; Sharma V; Ahsan MJ
ACS Omega; 2023 Aug; 8(30):26837-26849. PubMed ID: 37593245
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, Anticancer Activity, and In Silico Studies of 5-(3-Bromophenyl)-
Ahsan MJ; Gautam K; Ali A; Ali A; Altamimi ASA; Salahuddin ; Alossaimi MA; Lakshmi SVVNSM; Ahsan MF
Molecules; 2023 Oct; 28(19):. PubMed ID: 37836779
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and Anticancer Evaluation of 4-Chloro-2-((5-aryl-1,3,4-oxadiazol-2-yl)amino)phenol Analogues: An Insight into Experimental and Theoretical Studies.
Afzal O; Ali A; Ali A; Altamimi ASA; Alossaimi MA; Bakht MA; Salahuddin ; Alamri MA; Ahsan MF; Ahsan MJ
Molecules; 2023 Aug; 28(16):. PubMed ID: 37630338
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and anticancer activity of N-aryl-5-substituted-1,3,4-oxadiazol-2-amine analogues.
Ahsan MJ; Sharma J; Singh M; Jadav SS; Yasmin S
Biomed Res Int; 2014; 2014():814984. PubMed ID: 24977160
[TBL] [Abstract][Full Text] [Related]
5. An Efficient Synthesis of 1-(1,3-Dioxoisoindolin-2-yl)-3-aryl Urea Analogs as Anticancer and Antioxidant Agents: An Insight into Experimental and
Afzal O; Ahsan MJ
Molecules; 2023 Dec; 29(1):. PubMed ID: 38202650
[TBL] [Abstract][Full Text] [Related]
6. Rationale Design, Synthesis, Cytotoxicity Evaluation, and Molecular Docking Studies of 1,3,4-oxadiazole Analogues.
Ahsan MJ; Choupra A; Sharma RK; Jadav SS; Padmaja P; Hassan MZ; Al-Tamimi ABS; Geesi MH; Bakht MA
Anticancer Agents Med Chem; 2018; 18(1):121-138. PubMed ID: 28425854
[TBL] [Abstract][Full Text] [Related]
7. Chemical Modification of Curcumin into Its Semi-Synthetic Analogs Bearing Pyrimidinone Moiety as Anticancer Agents.
Afzal O; Yusuf M; Ahsan MJ; Altamimi ASA; Bakht MA; Ali A; Salahuddin
Plants (Basel); 2022 Oct; 11(20):. PubMed ID: 36297760
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and Evaluation of 2-Naphthaleno trans-Stilbenes and Cyanostilbenes as Anticancer Agents.
Madadi NR; Penthala NR; Ketkar A; Eoff RL; Trujullo-Alonso V; Guzman ML; Crooks PA
Anticancer Agents Med Chem; 2018; 18(4):556-564. PubMed ID: 28403783
[TBL] [Abstract][Full Text] [Related]
9. Chemical Characterization,
Ansari JA; Ahmad MK; Fatima N; Azad I; Mahdi AA; Satyanarayan GNV; Ahmad N
Anticancer Agents Med Chem; 2022; 22(20):3416-3437. PubMed ID: 35125087
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and docking studies of novel 4-aminophenol-1,2,4-oxadiazole hybrids as apoptosis inducers against triple negative breast cancer cells targeting MAP kinase.
Dhanalakshmi B; Anil Kumar BM; Srinivasa Murthy V; Srinivasa SM; Vivek HK; Sennappan M; Rangappa S
J Biomol Struct Dyn; 2023 Aug; ():1-17. PubMed ID: 37529915
[TBL] [Abstract][Full Text] [Related]
11. Oxadiazol-based mTOR inhibitors with potent antiproliferative activities: synthetic and computational modeling.
Khanfar MA
Mol Divers; 2022 Dec; 26(6):3357-3364. PubMed ID: 34985718
[TBL] [Abstract][Full Text] [Related]
12. Design and synthesis of newer 1,3,4-oxadiazole and 1,2,4-triazole based Topsentin analogues as anti-proliferative agent targeting tubulin.
Naaz F; Ahmad F; Lone BA; Pokharel YR; Fuloria NK; Fuloria S; Ravichandran M; Pattabhiraman L; Shafi S; Shahar Yar M
Bioorg Chem; 2020 Jan; 95():103519. PubMed ID: 31884140
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of Combretastatin-A4 Carboxamidest that Mimic Sulfonyl Piperazines by a Molecular Hybridization Approach: in vitro Cytotoxicity Evaluation and Inhibition of Tubulin Polymerization.
Jadala C; Sathish M; Anchi P; Tokala R; Lakshmi UJ; Reddy VG; Shankaraiah N; Godugu C; Kamal A
ChemMedChem; 2019 Dec; 14(24):2052-2060. PubMed ID: 31674147
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, in vitro and in silico evaluation of a new series of oxadiazole-based anticancer agents as potential Akt and FAK inhibitors.
Altıntop MD; Sever B; Akalın Çiftçi G; Turan-Zitouni G; Kaplancıklı ZA; Özdemir A
Eur J Med Chem; 2018 Jul; 155():905-924. PubMed ID: 29966916
[TBL] [Abstract][Full Text] [Related]
15. Design, Synthesis, Anticancer Evaluation, and Molecular Docking Studies of Novel Benzoxazole Linked 1,3,4-Oxadiazoles.
Bujji S; Kumar EP; Sivan SK; Manjunatha DH; Subhashini NJP
Anticancer Agents Med Chem; 2022; 22(5):933-942. PubMed ID: 34229589
[TBL] [Abstract][Full Text] [Related]
16. Hydrazide-hydrazones as Small Molecule Tropomyosin Receptor Kina se A (TRKA) Inhibitors: Synthesis, Anticancer Activities,
Alam MS; Lee DU
Med Chem; 2022; 19(1):47-63. PubMed ID: 35490310
[TBL] [Abstract][Full Text] [Related]
17. Design and synthesis of 4-aminophenol-1,3,4-oxadiazole derivative potentiates apoptosis by targeting MAP kinase in triple negative breast cancer cells.
Dhanalakshmi B; Anil Kumar BM; Muddenahalli Srinivasa S; Vivek HK; Sennappan M; Rangappa S; Srinivasa Murthy V
J Biomol Struct Dyn; 2023 Nov; ():1-16. PubMed ID: 37948299
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, modelling studies and biological evaluation of 1,3,4-oxadiazole derivatives as potent anticancer agents targeting thymidine phosphorylase enzyme.
Bajaj S; Kumar MS; Tinwala H; Yc M
Bioorg Chem; 2021 Jun; 111():104873. PubMed ID: 33845381
[TBL] [Abstract][Full Text] [Related]
19. 2,5-Bis(2,2,2-trifluoroethoxy)phenyl-tethered 1,3,4-Oxadiazoles Derivatives: Synthesis, In Silico Studies, and Biological Assessment as Potential Candidates for Anti-Cancer and Anti-Diabetic Agent.
Shankara SD; Isloor AM; Kudva AK; Raghu SV; Jayaswamy PK; Venugopal PP; Shetty P; Chakraborty D
Molecules; 2022 Dec; 27(24):. PubMed ID: 36557829
[TBL] [Abstract][Full Text] [Related]
20. Anticancer activity of newly synthesized azaphenothiazines from NCI's anticancer screening bank.
Pluta K; Jeleń M; Morak-Młodawska B; Zimecki M; Artym J; Kocieba M
Pharmacol Rep; 2010; 62(2):319-32. PubMed ID: 20508288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]